Fennec Pharmaceuticals Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP FENC

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

17,023

Value ($000)

159

Weight

0.0%

2019 Q4 - 2025 Q3 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	159	0.0%	17,023	9/30/2025
2025 Q2	8/14/2025	389	0.0%	46,851	6/30/2025
2025 Q1	5/14/2025	184	0.0%	30,258	3/31/2025
2024 Q4	2/14/2025	79	0.0%	12,432	12/31/2024
2024 Q1	5/7/2024	251	0.0%	22,599	3/31/2024
2023 Q4	2/14/2024	169	0.0%	15,040	12/31/2023
2023 Q2	8/11/2023	101	0.0%	11,429	6/30/2023
2023 Q1	5/16/2023	1,342	0.0%	161,320	3/31/2023
2022 Q4	2/14/2023	1,033	0.0%	107,613	12/31/2022
2022 Q2	8/15/2022	277	0.0%	49,075	6/30/2022
2022 Q1	5/16/2022	750	0.0%	133,964	3/31/2022
2021 Q4	2/14/2022	590	0.0%	134,101	12/31/2021
2021 Q3	11/15/2021	254	0.0%	26,942	9/30/2021
2021 Q2	8/11/2021	105	0.0%	14,398	6/30/2021
2020 Q4	2/16/2021	85	0.0%	11,368	12/31/2020
2020 Q3	11/16/2020	199	0.0%	32,860	9/30/2020
2020 Q2	8/14/2020	1,327	0.0%	158,948	6/30/2020
2020 Q1	5/15/2020	526	0.0%	88,518	3/31/2020
2019 Q4	2/14/2020	368	0.0%	56,776	12/31/2019